Duchesnay Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Duchesnay Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10896
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Duchesnay Inc (Duchesnay) is a pharmaceutical company that offers medications for use in pregnancy. The company’s products include diclectin, an antinauseant drug used for the management of nausea and vomiting; pregvit, a supplement that allow attaining nutrient levels of folic acid, iron, and calcium; and proctofoam-HC, a mucoadhesive analgesic and anti-inflammatory foam for the relief of anorectal inflammation and swelling. It also provides ladysystem, a feminine therapy to treat urinary stress incontinence caused by pelvic floor weakening; and mictoryl indicated for symptomatic treatment of urinary incontinence or increased urinary frequency and urgency in patients with overactive bladder. The company markets pharmaceutical products and medical devices in a variety of therapeutic areas, including obstetrics and gynecology, proctology, urology, and bacterial vaginosis. Duchesnay is headquartered in Blainville, Quebec, Canada.

Duchesnay Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Duchesnay Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Duchesnay Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Duchesnay Enters Into Distribution Agreement With Tzamal Medical For Diclectin Drug 10
Licensing Agreements 11
Duchesnay Receives Rights for Osphena from Shionogi 11
Alliance Pharma Enters into Licensing Agreement with Duchesnay for Diclectin 12
Duchesnay Inc – Key Competitors 13
Duchesnay Inc – Key Employees 14
Duchesnay Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Product News 16
07/06/2018: Alliance Pharma Marketing Authorisation for Diclectin in the UK 16
06/25/2018: Actress, Mom and Singer Jana Kramer is Expecting and Again Partnering with Duchesnay USA to Spread the Word about Bonjesta (doxylamine succinate – pyridoxine hydrochloride) 17
04/02/2018: Duchesnay USA Announces Availability of Bonjesta (doxylamine succinate – pyridoxine hydrochloride) in the United States 18
Product Approvals 19
Jun 07, 2018: Alliance Pharma Announces Positive Opinion for Diclectin 19
Jul 28, 2017: Alliance Pharma announce Update on Diclectin 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Duchesnay Inc, Pharmaceuticals & Healthcare, Key Facts 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Duchesnay Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Duchesnay Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Duchesnay Enters Into Distribution Agreement With Tzamal Medical For Diclectin Drug 10
Duchesnay Receives Rights for Osphena from Shionogi 11
Alliance Pharma Enters into Licensing Agreement with Duchesnay for Diclectin 12
Duchesnay Inc, Key Competitors 13
Duchesnay Inc, Key Employees 14
Duchesnay Inc, Subsidiaries 15

List of Figures
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Duchesnay Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Himatsingka Seide Ltd:企業の戦略・SWOT・財務情報
    Himatsingka Seide Ltd - Strategy, SWOT and Corporate Finance Report Summary Himatsingka Seide Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • HD Supply Inc (HDS):企業の財務・戦略的SWOT分析
    HD Supply Inc (HDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Norsk Hydro ASA:企業の戦略・SWOT・財務情報
    Norsk Hydro ASA - Strategy, SWOT and Corporate Finance Report Summary Norsk Hydro ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Petrichor Energy Inc (PTP):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrichor Energy Inc (Petrichor Energy), formerly Odyssey Petroleum Corp is an oil and gas company that acquires, explores and develops oil and natural gas reserves in the Americas. The company provides projects such as Verba Field, Marble Falls Prospect, and others. It offes its services fo …
  • Vertex Pharmaceuticals Incorporated:企業の戦略・SWOT・財務分析
    Vertex Pharmaceuticals Incorporated - Strategy, SWOT and Corporate Finance Report Summary Vertex Pharmaceuticals Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Wockhardt Ltd (WOCKPHARMA):製薬・医療:M&Aディール及び事業提携情報
    Summary Wockhardt Ltd (Wockhardt) is a pharmaceutical company that manufactures and markets vaccines, active pharmaceutical ingredients, pharmaceutical and recombinant bio-pharmaceutical formulations. The company's product portfolio caters to various therapeutic areas including orthopedics, dental c …
  • Skyworth Digital Holdings Limited:企業の戦略・SWOT・財務情報
    Skyworth Digital Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Skyworth Digital Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Energia Argentina SA:電力:M&Aディール及び事業提携情報
    Summary Energia Argentina SA (ENARSA) is a state owned energy company that explores and exploits hydrocarbons in solid, liquid and gaseous states. It stores, transports, distributes, markets and industrializes the hydrocarbons and their derivatives. Energia conducts design, construction, commissioni …
  • Highland Gold Mining Limited
    Highland Gold Mining Limited - Strategy, SWOT and Corporate Finance Report Summary Highland Gold Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Tarsus Group Plc:企業のM&A・事業提携・投資動向
    Tarsus Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Tarsus Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Seegene Inc (096530):企業の財務・戦略的SWOT分析
    Summary Seegene Inc (Seegene) is a diagnostic company that develops molecular diagnostic reagents. The company provides products such as seeplex, anyplex and magicplex among others. It develops ACP, DPO, READ, MuDT and TOCE technologies that enables to detect multiple pathogens in single reactions u …
  • Futura Medical Plc (FUM):製薬・医療:M&Aディール及び事業提携情報
    Summary Futura Medical Plc (Futura Medical) is a pharmaceutical company that focuses on research and development of novel products for various therapeutic areas, including sexual health and pain relief management. The company focuses on developing pharmaceutical products based on its transdermal dru …
  • Cara Therapeutics Inc (CARA):医療機器:M&Aディール及び事業提携情報
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities for acutepain, chronic pain and pruritus. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruri …
  • Micell Technologies Inc:製品パイプライン分析
    Summary Micell Technologies Inc (Micell) is a medical device company that develops drug delivery systems for the treatment of cardiovascular diseases. The company offers product such as MiStent sirolimus eluting absorbable polymer coronary stent system, a drug-eluting stent that is designed to optim …
  • Aarti Industries Ltd (AARTIIND):企業の財務・戦略的SWOT分析
    Summary Aarti Industries Ltd (Aarti Industries) is a chemical company that manufactures and markets benzene based basic and intermediate chemicals. It offers chemicals, pharma products and surfactants including rubber chemicals, dyes and pigment intermediates; surfactant intermediates, pharmaceutica …
  • Tractebel Engineering:企業の戦略的SWOT分析
    Tractebel Engineering - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • American Airlines Group Inc (AAL):企業の財務・戦略的SWOT分析
    American Airlines Group Inc (AAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Carnarvon Petroleum Ltd (CVN):石油・ガス:M&Aディール及び事業提携情報
    Summary Carnarvon Petroleum Ltd (Carnarvon Petroleum) is an oil and gas company that acquires, explores, and develops oil and gas properties. The company's projects comprise Cerberus and the Phoenix project. It has assets in Barrow sub-basin, Perth basin, and Roebuck basin. Carnarvon Petroleum's Pho …
  • CGN New Energy Holdings Co Ltd (1811):企業の財務・戦略的SWOT分析
    CGN New Energy Holdings Co Ltd (1811) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Aptuit LLC-製薬・医療分野:企業M&A・提携分析
    Summary Aptuit LLC (Aptuit) is a provider of drug discovery and development services. The company offer wide range of services such as manufacturing, project management, small and large molecules analysis, formulation development, integrated chemistry, API route scouting and process development, con …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆